Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.1 | 0.3 | 806.4 | 18.0 | 21.3 | 92.2 | 13.4 | 37.0 |
| Revenue growth | -83.1% | -100.0% | 4387.7% | -15.8% | -76.8% | 587.9% | -63.8% | -54.6% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.4 |
| Gross profit | 0.1 | 0.3 | 806.4 | 18.0 | 21.3 | 92.2 | 13.4 | 30.6 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 82.8% |
| Selling, general and administrative | 126.2 | 103.2 | 77.6 | 45.3 | | | | |
| Research and development | 419.5 | 323.7 | 231.5 | 115.0 | 71.0 | 63.8 | 83.3 | 100.3 |
| General and administrative | | | | | 30.3 | 27.5 | 30.3 | 34.1 |
| EBITA | -545.7 | -426.6 | 497.3 | -142.3 | -80.0 | 0.9 | -100.2 | -104.8 |
| EBITA margin | -1010483.3% | -133742.6% | 61.7% | -792.0% | -374.9% | 0.9% | -747.6% | -283.4% |
| Amortization of intangibles | | | | | | | | 0.5 |
| EBIT | -545.7 | -426.6 | 497.3 | -142.3 | -80.0 | 0.9 | -100.2 | -105.3 |
| EBIT margin | -1010483.3% | -133742.6% | 61.7% | -792.0% | -374.9% | 0.9% | -747.6% | -284.8% |
| Pre-tax income | -616.4 | -404.7 | 507.9 | -138.8 | -95.9 | -12.3 | -110.7 | -60.5 |
| Income taxes | 0.0 | 0.0 | 110.3 | 110.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 21.7% | | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -616.4 | -404.7 | 397.6 | -29.4 | -187.3 | -22.5 | -218.7 | -60.5 |
| Net margin | -1141542.6% | -126875.9% | 49.3% | -163.6% | -877.6% | -24.4% | -1632.2% | -163.7% |
| |
| Diluted EPS | ($10.14) | ($7.39) | $7.69 | ($0.62) | ($5.68) | ($0.93) | ($9.09) | ($0.28) |
| Shares outstanding (diluted) | 60.8 | 54.8 | 51.7 | 47.0 | 33.0 | 24.3 | 24.1 | 219.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|